Hypothyroidism is often associated with psychiatric disorders such as depression. In this study, we evaluated the effect of chrysin on depressive-like behavior and monoamine levels in hypothyroid female mice. Hypothyroidism was induced by continuous exposure to 0.1% methimazole (MTZ) in drinking water for 31 days. Exposure to MTZ was associated with low plasma levels of thyroid hormones T3 and T4 compared with the control group. Subsequently, euthyroid and MTZ-induced hypothyroid mice were intragastrically administered vehicle or chrysin (20 mg/kg) once a day for 28 consecutive days. After treatments, the following behavioral assessments were performed: Open-Field Test (OFT), Tail suspension test (TST), and Forced Swimming Test (FST). Additionally, T3 and T4 levels were measured again, and serotonin (5HT), dopamine, and noradrenaline levels were analyzed in the prefrontal cortex and the hippocampus. Chrysin treatment could not reverse T3 and T4 levels. Hypothyroid mice showed an increased immobility time in TST and FST; chrysin treatment reversed these effects. Reduced levels of 5HT and dopamine in the prefrontal cortex and the hippocampus were observed in the hypothyroid mice than in the euthyroid mice. Chrysin treatment recovered 5HT content in both structures and dopamine content only in the hippocampus. Noradrenaline content was not altered by treatments. Together, our results have demonstrated that chrysin treatment reverses depressive-like behaviors in hypothyroid female mice and suggests the involvement of 5HT and dopamine in these effects.
Introduction
Imbalances in thyroid hormones are associated with functional and structural brain alterations (Ge et al., 2016) . Indeed, clinical observations have demonstrated that disturbances in thyroid function could result in the dysfunction of many organs, thus inducing neurobehavioral alterations . It has been reported that hypothyroidism has a close relationship with psychiatric disorders such as depression (Colin and Vijay, 2013) . Patients with hypothyroidism usually display various types of depression behaviors including cognitive dysfunction, apathy, dull/boring reactions, and low sociability . Furthermore, studies have demonstrated sex differences associated with hypothyroidism and mood disorders, whereby the prevalence of hypothyroidism and depression is 10% higher in women than in men (Tong et al., 2007; Morganti et al., 2005; Brunet et al., 2014; Habel et al., 2015; Hiles et al., 2015; Kessler, 2003) .
Depression is associated with reduced levels of monoamine neurotransmitters, such as serotonin (5HT), dopamine, and norepinephrine or impaired activity of their receptors (Racagni and Popoli, 2010; Nemeroff, 2007) . The development of the monoaminergic system is delayed in hypothyroid rodents (Ahmed et al., 2008 (Ahmed et al., , 2010 . Furthermore, thyroid hormones might regulate the expression of proteins involved in the modulation of neurotransmitter release (Vara et al., 2002) . Additionally, several reports demonstrate a close association between depression-like behaviors and decreased 5HT brain levels in hypothyroid rats (Ito et al., 1977; Jacoby et al., 1975; Bauer et al., 2002; Tousson et al., 2012) .
Globally, more than 300 million people of all ages suffer from depression, which is equivalent to 4.4% of the world's population (WHO, 2017) . It remains challenging to identify an efficient treatment for depression because available antidepressants are frequently associated with adverse reactions (Amitai et al., 2016) . Thus, the search for drugs or phytochemicals with minimal side effects for the treatment of depression is becoming increasingly relevant. The therapeutic effects of flavonoids isolated from plants on depression models have been previously reported (Antunes et al., 2016; Su et al., 2016; Wang et al., 2016; Weng et al., 2016) . For example, it has been recently demonstrated that the natural flavonoid chrysin (5,7-Dihydroxyflavone, Fig. 1 ) exhibits potent anxiolytic (Wolfman et al., 1994) and antidepressant-like effects in several experimental models. These effects have been further associated with the modulation of the central serotoninergic system and brain-derived neurotropic factor (Filho et al., 2015 (Filho et al., , 2016a (Filho et al., , 2016b . In view of these considerations, our study aims to evaluate whether treatment with chrysin reverses depressive-like behaviors in hypothyroid female mice, and whether monoamine modulation is involved.
Materials and methods

Drug solutions and administration
Chrysin ( Fig. 1) and methimazole (MTZ) were purchased from Sigma-Aldrich (St. Louis, MO, USA). All other chemicals were obtained from analytical grade of our laboratory or from standard commercial suppliers.
Chrysin was dissolved in 20% polietilenglicol and saline solution (pH 7.4, 80%), while MTZ was dissolved in saline solution (pH 7.4). The MTZ dose used in our study was according to that used by Li et al. (2012) , while the chrysin dose was according to that used by Filho et al. (2015) .
Animals
A total of 56 adult female C57BL/6 mice (age, 3-4 months), assigned by the Federal University of Santa Maria, were used. Animals were maintained in a room at a controlled temperature (22-25°C) under a 12-h dark-light cycle, and received food and the water ad libitum before the treatment. All manipulations were carried out between 08.00 a.m. and 04.00 p.m. The present experimental study was approved by the Institutional Ethics Committee on Care and Use of Experimental Animal Resources from the Federal University of Pampa, Brazil, and was registered under the number 027/2016. All efforts were made to minimize animal suffering and to reduce the number of animals used in the experiments.
Experimental protocol
Hypothyroidism induction
First, the animals were divided into two groups: control (n = 28) and MTZ (n = 28; Fig. 2 ). Hypothyroidism was induced by continuous exposure to the anti-thyroid drug MTZ 0.1% + 0.475% sucralose in the drinking water for 31 days (Li et al., 2012) . The control group received 0.475% sucralose in the drinking water. After treatments, the levels of total thyroid hormones T3 and T4 were measured using blood extracted from the mice tail vein. Exposure to MTZ was associated with low T3 and T4 plasma levels compared with the control group.
Chrysin treatment
To evaluate the effect of chrysin on this model, the euthyroid and hypothyroid mice were subdivided into four groups (n = 14 each): euthyroid; euthyroid chrysin; hypothyroid; and hypothyroid chrysin. Chrysin (20 mg/kg) was administered intragastrically once a day for 28 consecutive days (Filho et al., 2015) (Fig. 2) . Subsequently, the levels of total T3 and T4 were measured again.
Thyroid hormone levels
Plasma levels of total T4 and T3 were measured through a microparticle enzyme immunoassay (MEIA) using the AxSYM® system (Abbott Laboratories, Abbott Park, Illinois, USA), according to the manufacturer's instructions; T3 was expressed in ng/ml and T4 in pg/ ml.
Behavioral assessments
At the end of chrysin treatment, behavioral assessments were performed in the following order: Open-Field Test (OFT), Tail Suspension Test (TST), and Forced Swimming Test (FST).
Open-field test
The OFT was performed in a 45-cm 2 plastic box with 30-cm high walls. The OFT box was connected to a computer. Animals were placed at the center of the apparatus, and were observed for 5 min. Locomotor activity was assessed through the distance traveled in meters. The apparatus was cleaned with 70% alcohol between trials to avoid possible influence on locomotion (Walsh and Cummins, 1976) .
Tail suspension test
The TST was conducted as initially described by Steru et al. (1985) . The animals were individually suspended by the tail from a horizontal ring stand bar raised 30 cm above the ground, using adhesive tape placed 1 cm from the tip of the tail and positioned such that the base of the tail was aligned with the horizontal plane. The duration of the test was 6 min. The total immobility time was recorded for each animal in seconds. Immobility was considered in case of complete absence of all movements except for those required for respiration.
Forced swimming test
The FST was performed according to the procedure of Porsolt et al. (1977b) . The test apparatus consisted of a transparent cylindrical polypropylene tank (46 cm height × 35 cm diameter) containing 40 cm of water at 25 ± 1°C to prevent the animals from escaping. The water was changed between the tested animals. The duration of immobility was recorded for 5 min. Immobility corresponded to the total time 
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Tissue preparation
After the behavioral tests, animals were anesthetized, and blood samples were collected directly from the ventricle of their heart, using heparin as the anticoagulant. Blood was used to analyze T3 and T4 levels, and plasma was separated by centrifugation (2400 ×g) for 15 min. The prefrontal cortex and the hippocampus were removed and homogenized in 50 mM Tris-HCl, pH 7.4 (1:5, w-v). The homogenates were subsequently centrifuged at 2400 ×g at 4°C for 15 min. A lowspeed supernatant fraction (S1) was used to measure the levels of 5HT, dopamine, and noradrenaline.
Monoamine levels
The levels of 5HT, dopamine, and noradrenaline were measured in the prefrontal cortex and the hippocampus using reverse-phase highperformance liquid chromatography with electrochemical detection as previously described (Han et al., 2015) .
Monoamines were isolated on a reverse-phase column (MD 150; ESA, Inc.), and quantified using a coulometric detector (Coulochem III; ESA, Inc.) consisting of a guard cell (electrode: +300 mV; 5020 guard cell; ESA, Inc.) and a dual channel analytical cell (first electrode: −150 mV, second electrode: +220 mV; 5011 A High Sensitivity Analytical Cell; ESA, Inc.). The signals emitted by the second analytical electrode were recorded and analyzed using EZChrom SI version 3.2 (Agilent Technologies, Palo Alto, Calif, USA) (Han et al., 2015) . The concentrations of 5HT, dopamine, and noradrenaline were measured and expressed as ng/g of tissue.
Statistical analysis
The data were analyzed using Prism 5 (GraphPad) and StatSoft 10 software. Comparisons between the experimental and control groups were performed using one-way analysis of variance (ANOVA), followed by Newman Keuls post-hoc test or two-way ANOVA (hypothyroidism × chrysin) followed by Bonferroni post-hoc test when appropriate. The main effects were presented only when the second order interaction was not significant. Pearson's correlation coefficient was used for the estimation of the correlation between the analyzed parameters. Descriptive data were expressed as the mean(s) ± standard error of the mean (S.E.M.). Probability values less than 0.05 (P < 0.05) were considered statistically significant.
Results
Thyroid hormone levels
One-way ANOVA followed by post-hoc comparisons demonstrated that exposure to MTZ was associated with low T3 (P = 0.000000) and T4 (P = 0.000000) plasma levels than the control group (Fig. 3A) . The results also indicated a significant main effect of MTZ on the levels of T3 (F 1, 12 = 3174, P < 0.0001) and T4 (F 1, 12 = 15574.04, P < 0.0001).
The effect of chrysin on the serum levels of T3 and T4 in the mice at the end of the treatment are shown in Fig. 3B and C, respectively. Twoway ANOVA followed by post-hoc comparisons revealed a decrease in the levels of both T3 (P = 0.001989) and T4 (P = 0.028139) in hypothyroid mice compared with euthyroid mice. Treatment with chrysin could not reverse these effects. A significant main effect of hypothyroidism on T3 (F 1,12 = 23.99, P = 0.0004) and T4 (F 1,12 = 21.62, P = 0.0006) was also observed.
Behavioral tests 3.2.1. Open-field test
Two-way ANOVA followed by post-hoc comparisons revealed that there was no significant difference among the groups in the locomotor and exploratory activities (Fig. 4) . No significant main effect of chrysin, hypothyroidism, and hypothyroidism × chrysin interaction was found in these parameters (F 1, 49 = 0.01, P = 0.9186). Fig. 5A shows the immobility time during the TST. The data reveal a significant increase in the immobility time of hypothyroid mice compared with euthyroid mice (P = 0.000340); treatment with chrysin reversed this effect (P = 0.000499). Two-way ANOVA followed by post-hoc comparisons of immobility time in the TST revealed a significant hypothyroidism × chrysin interaction (F 1, 36 = 17.14, P = 0.0002).
Fig . 5B shows the immobility time during the FST. The data reveals that hypothyroidism caused a significant increase in the immobility time as compared with the euthyroid mice (P = 0.021375); chrysin effectively reversed this effect (P = 0.000315). Two-way ANOVA followed by posthoc comparisons revealed a significant hypothyroidism × chrysin interaction (F 1, 48 = 7.81, P = 0.0074) on immobility time in the FST.
3.3. Monoamine levels in the prefrontal cortex and hippocampus Fig. 6A and B demonstrate the effect of chrysin on 5HT levels in the hippocampus and the prefrontal cortex, respectively. Post-hoc analysis revealed that hypothyroidism decreased 5HT levels in both the hippocampus (P = 0.010200) and the prefrontal cortex (P = 0.002930), when compared to the euthyroid mice. Treatment with chrysin recovered this level in both brain regions (hippocampus, P = 0.039510; prefrontal cortex, P = 0.003917). Two-way ANOVA of the 5HT levels demonstrated a significant hypothyroidism × chrysin interaction in the hippocampus (F 1,12 = 4.35, P = 0.0589) and the prefrontal cortex (F 1,12 = 12.92, P = 0.0037). Fig. 7A and B show the effect of chrysin on dopamine levels in the hippocampus and the prefrontal cortex, respectively. Post-hoc analysis revealed that hypothyroidism decreased the dopamine level in both brain structures (hippocampus, P = 0.023510; prefrontal cortex, P = 0.000779), compared with euthyroid mice. Treatment with chrysin reversed this effect significantly only in the hippocampus (P = 0.004036). Two-way ANOVA of the dopamine levels demonstrated a significant hypothyroidism × chrysin interaction in the hippocampus (F 1,12 = 10.11, P = 0.0079). Fig. 8A and B display the effects of chrysin on noradrenaline levels in the hippocampus and the prefrontal cortex, respectively. Post-hoc analysis of the noradrenaline level revealed no significant difference among the groups. Two-way ANOVA also indicated no significant hypothyroidism × chrysin interaction in both structures, hippocampus (F 1, 12 = 0.33, P = 0.5753) and prefrontal cortex (F 1, 12 = 0.79, P = 0.3930). 
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Correlation analysis
Pearson's correlation analysis indicated a significant negative correlation between the 5HT levels and FST results in the hippocampus (r = −0.5746; P = 0.0199; Fig. 9A ) and prefrontal cortex (r = −0.7707; P = 0.0005; Fig. 9B ). Furthermore, we observed a significant negative correlation between the dopamine levels and TST results in the hippocampus (r = −0.8617; P < 0.0001; Fig. 9C ) and prefrontal cortex (r = −0.7412; P = 0.0010; Fig. 9D ).
Discussion
The present study demonstrates the effectiveness of chrysin treatment on depressive-like behaviors in hypothyroid female mice. In our study, hypothyroidism led to increased depression-like behaviors, together with decreased 5HT and dopamine levels in the prefrontal cortex and the hippocampus. Treatment with chrysin could reverse these behavioral and neurochemical alterations. The antidepressant-like effect of chrysin was obtained independently of the thyroid hormone levels, which remained low even after treatment with chrysin.
Based on the behavioral results, the locomotor activity was not altered in hypothyroid mice, which is in contrast to the hypoactivity reported in people with hypothyroidism. Our results confirmed the modulatory effect of MTZ on cognitive functions as evidenced by the preserved locomotor and exploratory activities in the OFT. Our study also demonstrated that the anti-immobility effect of chrysin cannot be attributed to any psychostimulant action, since chrysin did not alter the locomotor activity in the OFT.
The FST and TST are known tests for behavioral despair and enable probing the pathological mechanism of depression and evaluating the effects of antidepressants (Porsolt et al., 1978) . The duration of immobility reflects the state of hopelessness to escape a challenging situation, which is a symptom most commonly seen in humans (Castagné et al., 2011; Liang et al., 2016) . In the present study, hypothyroidism increased the immobility duration in both tests. It has already been reported that hypothyroidism causes depressive-like behaviors (Dias et al., 2014 ). An important finding in the present study is that chrysin exhibited protective effects against the increased immobility time, hence depressive-like behaviors, based on the results in both FST and TST. These results confirm corroborated the previously reported antidepressant potential of chrysin following unpredictable chronic stress (Filho et al., 2015 (Filho et al., , 2016a , and in a model of chronic unpredictable mild stress and olfactory bulbectomy (Filho et al., 2016b) .
Both FST and TST are widely used for screening potential antidepressant agents and are sensitive and relatively specific to all major classes of antidepressants, including tricyclic antidepressant (TCAs), European Journal of Pharmacology 822 (2018) 78-84 selective serotonin reuptake inhibitors (SSRIs), monoamine oxidase inhibitors (MAOIs), and atypical antidepressants (Porsolt et al., 1977a; Detke et al., 1995; Steru et al., 1985; Adongo et al., 2015) . These tests are based on observations in rodents, and both models indicate a correlation between antidepressant efficacy and clinical potency (Adongo et al., 2015) . In the FST, substances that increase the swimming time without altering the climbing behavior are purported to be acting via the serotoninergic pathway, while those that increase the climbing score without affecting swimming are act via the noradrenergic pathway (Page et al., 1999; Rénéric et al., 2001; Kukuia et al., 2015) . The mechanism of action of TST is dependent on the dopaminergic system and particularly on dopamine receptors D 1 and D 2 (Hirano et al., 2007; Donato et al., 2013) . Based on the behavioral results, hypothyroidism increased the immobility time, while chrysin reversed this effect. Thus, we assume that chrysin may act by modulating the levels of 5HT and dopamine. It is well known that monoamines play an important role in depression (Liang et al., 2016; Sarris et al., 2011; Kwon et al., 2010) . For example, 5HT is an important neurotransmitter in depression states, and a dysfunctional 5HT system is generally regarded as a risk factor for depression (Han et al., 2015) . On the other hand, thyroid hormones are implicated in serotonergic neurotransmission, whereby they affect the sensitivity of 5HT receptors in the raphe nucleus particularly by upregulating the sensitivity of 5HT1A receptors and reducing that of the 5HT2 receptors. Thus, the thyroid hormones could increase the 5HT levels by inhibiting 5HT receptors in the raphe nucleus (Kalra and Balhara, 2014; Zhang et al., 2016) . It has previously been reported that thyroid hormones influence the activity of the serotoninergic system and the functioning of its receptors (Kulikov et al., 1999) . In addition, 5HT may have some connections with the circulating levels of thyroid hormones (Upadhyaya and Agrawal, 1993) . Previous studies have demonstrated a close association between depression-like behaviors and decreased 5HT levels in hypothyroid rats (Ito et al., 1977; Jacoby et al., 1975; Bauer et al., 2002; Tousson et al., 2012) . Our results demonstrated that hypothyroid mice presented a decrease in the 5HT levels in the hippocampus and prefrontal cortex. In addition, the strong negative correlation between the 5HT levels in the hippocampus and prefrontal cortex and the FST results confirms the involvement of the serotoninergic system in depression-like behaviors. Our results are in accordance with previous observations in rat models of hypothyroidism induced by thyroidectomy and propylthiouracil (PTU) (Hassan et al., 2013) . Chrysin recovered the levels of 5HT in the hippocampus and prefrontal cortex. This result confirms the involvement of the serotoninergic system in the antidepressant-like effect of chrysin in the FST test. This observation is important because both the hippocampus and prefrontal cortex are implicated in the regulation of emotion, motivation, learning, and memory, which are all associated with depression (Ye et al., 2015) . Furthermore, Filho et al. (2016a) also associated the antidepressant-like effect of chrysin in mice exposed to unpredictable chronic stress (UCS) with the serotoninergic system. Dopamine is another neurotransmitter associated with depression, and has already been described as the principal neurotransmitter that mediates locomotion and motivates behavior (Ide et al., 2016) . The TST has been extensively used for the assessment of depression-like behaviors in experimental mouse models, and is reported to act on the dopaminergic system. Our study demonstrated that the dopamine levels in the hippocampus and prefrontal cortex were decreased in hypothyroid mice compared with the controls. In addition, we observed a strong negative correlation between the dopamine levels in the hippocampus and prefrontal cortex of hypothyroid mice, which was confirmed by the TST results. Our results are in accordance with the study carried out by Hassan et al. (2013) that reported a significant reduction in dopamine levels in young and adult rats with hypothyroidism induced by PTU. Chrysin was effective in normalizing the dopamine level in the hippocampus, but not in the cortex. Our results confirmed the involvement of the dopaminergic system in the antidepressant-like effect of chrysin.
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Based on our results, it is conceivable that chrysin acts at the level of cerebral synaptogenesis, restoring 5HT and dopamine levels in the synaptic cleft, upon the synthesis or uptake of these neurotransmitters. However, further research is needed to confirm the pathway underlying the effects of chrysin on 5HT and dopamine in hypothyroidism-associated depression.
In our study, the noradrenaline levels were not altered in the hippocampus and prefrontal cortex. Different results were observed by Hassan et al. (2013) in a model of hypothyroidism induced by PTU, where a significant reduction of the noradrenaline levels was observed. This discrepancy may be due to the different experimental conditions. This study has proposed for the first time that depressive-like behavior in hypothyroid female mice was not correlated to alterations in the noradrenergic system.
Conclusion
Taken together, our findings demonstrate for the first time that chrysin treatment reverses the depressive-like behavior in hypothyroid female mice, and indicated that the antidepressant-like mechanism of chrysin was mediated, at least partly, by 5HT and dopamine mainly in the hippocampus.
